Thus far, SOAT1 has exhibited a prognostic value in several types of cancers, and its blockade can inhibit the proliferation of neoplasm cells in various cancer types, including pancreatic cancer, glioma, prostate cancer, lung cancer, and adrenocortical carcinoma (13–17). This evidence concerns the gene SOAT1 and glioma.